Biotricity, Inc.
BTCY
$0.48
-$0.02-4.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.95% | 21.00% | 16.50% | 21.73% | 12.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.95% | 21.00% | 16.50% | 21.73% | 12.99% |
| Cost of Revenue | -12.80% | -9.71% | -20.04% | 6.22% | -9.45% |
| Gross Profit | 29.37% | 31.89% | 31.07% | 27.49% | 23.00% |
| SG&A Expenses | 2.49% | -27.90% | -29.24% | -20.53% | -35.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.05% | -16.82% | -26.75% | -10.97% | -29.59% |
| Operating Income | 188.98% | 125.24% | 71.90% | 86.82% | 85.92% |
| Income Before Tax | 55.76% | 81.81% | 53.72% | 56.23% | 57.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 55.76% | 81.81% | 53.72% | 56.23% | 57.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.76% | 81.81% | 53.72% | 56.23% | 57.68% |
| EBIT | 188.98% | 125.24% | 71.90% | 86.82% | 85.92% |
| EBITDA | 189.91% | 125.41% | 71.93% | 86.92% | 85.98% |
| EPS Basic | 60.68% | 94.15% | 83.55% | 83.96% | 83.34% |
| Normalized Basic EPS | 62.82% | 88.93% | 83.33% | 84.00% | 83.52% |
| EPS Diluted | 60.54% | 94.15% | 83.50% | 83.96% | 83.34% |
| Normalized Diluted EPS | 62.82% | 88.93% | 83.33% | 84.00% | 83.52% |
| Average Basic Shares Outstanding | 19.00% | 85.50% | 179.18% | 169.87% | 155.73% |
| Average Diluted Shares Outstanding | 19.00% | 85.50% | 179.18% | 169.87% | 155.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.29% | -1.72% | -- | -1.21% | -1.42% |